Form D · Biotechnology

Paterna BioSciences HoldCo Inc.

Salt Lake City, UT · CIK 0001989862

Offering snapshot reported Aug 12, 2026 · SEC filing

Reported sold
$6.32M
Offering amount: $11.2M
Investors reported
17
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 30, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 12, 2026Initial$6,322,375No comparison17SEC filing
Mar 21, 2024Initial$2,000,000No comparison1SEC filing
Sep 1, 2023Initial$125,000No comparison2SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-593929
Total offering amount includes a warrant for $743.27.

Source: Form D, filed Aug 12, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Deirdre Conway Director
James Hotaling Director
Daniel Mitchell Executive
Danny Mitchell Executive
Ryan Morley Director
Alexander Pastuszak Director, Executive
Abraham Meir Rosenbaum Director
Edward Rowland Director, Executive
Cynthia Tsai Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2749 E Parleys Way, Ste 100
Salt Lake City, UT, 84109
Phone: 415-412-2934